Platt, D.C.; Rink, J.; Braich, K.; McLauchlan, C.C.; Jones, M.A.
2′-3′-Cyclic Nucleotide 3′-Phosphodiesterase Inhibition by Organometallic Vanadium Complexes: A Potential New Paradigm for Studying CNS Degeneration. Brain Sci. 2021, 11, 588.
https://doi.org/10.3390/brainsci11050588
AMA Style
Platt DC, Rink J, Braich K, McLauchlan CC, Jones MA.
2′-3′-Cyclic Nucleotide 3′-Phosphodiesterase Inhibition by Organometallic Vanadium Complexes: A Potential New Paradigm for Studying CNS Degeneration. Brain Sciences. 2021; 11(5):588.
https://doi.org/10.3390/brainsci11050588
Chicago/Turabian Style
Platt, David C., Jonathan Rink, Kamaljit Braich, Craig C. McLauchlan, and Marjorie A. Jones.
2021. "2′-3′-Cyclic Nucleotide 3′-Phosphodiesterase Inhibition by Organometallic Vanadium Complexes: A Potential New Paradigm for Studying CNS Degeneration" Brain Sciences 11, no. 5: 588.
https://doi.org/10.3390/brainsci11050588
APA Style
Platt, D. C., Rink, J., Braich, K., McLauchlan, C. C., & Jones, M. A.
(2021). 2′-3′-Cyclic Nucleotide 3′-Phosphodiesterase Inhibition by Organometallic Vanadium Complexes: A Potential New Paradigm for Studying CNS Degeneration. Brain Sciences, 11(5), 588.
https://doi.org/10.3390/brainsci11050588